Mark Xue
About Mark Xue
Mark Xue is a Clinical Programming professional with over 20 years of experience in the pharmaceutical industry, currently working at Merck and Bristol-Myers Squibb.
Professional Roles in Clinical Programming
Mark Xue currently holds positions in Clinical Programming at Merck in the Greater Pittsburgh Area and at Bristol-Myers Squibb in Hopewell, NJ. He has previously worked at Endo Pharmaceuticals, Pfizer, Ovation Pharmaceuticals, Abbott Laboratories, and SCIREX Corporation, showcasing a robust career spanning over 20 years in various roles, including Sr Principal Programming Lead, Oncology, and Statistical Programming Manager.
Extensive Experience in the Pharmaceutical Industry
With over 20 years of experience in the pharmaceutical industry, Mark Xue has developed in-depth knowledge in statistics, clinical programming, technical data management, and the clinical operation of drug and diagnosis assay development. His skills include expertise in clinical reporting, statistical analysis for various therapeutic areas, trial phases, and CDISC standards and data implementation.
Educational Background in Applied Statistics
Mark Xue studied at Louisiana State University (LSU), where he obtained his Master's degree in Applied Statistics from 1991 to 1993. This educational foundation has underpinned his extensive career in statistical programming and clinical data management within the pharmaceutical industry.
Technical and Management Skills
Mark Xue is a SAS Certified Advanced Programmer with outstanding programming capabilities in various languages. He demonstrates excellent time management and interpersonal skills, coupled with substantial experience in resource and project management. He excels in process improvement, SOP development, and the incorporation of standard dictionary coding into specific database systems.
Roles at Bristol-Myers Squibb
Currently, at Bristol-Myers Squibb, Mark Xue is part of a company dedicated to improving health outcomes, promoting health equity, and enhancing patient care. The company offers patient assistance programs, collaborates globally to accelerate new therapy development, and invests in digital health technologies. Bristol-Myers Squibb's Study Connect platform provides clinical trial information, and its foundation focuses on improving health outcomes for underserved populations.